HomePANACEABIO › Filing
🔔 Get instant alerts when PANACEABIO files quarterly results on BSE Start free trial →
Panacea Biotec Limited (PANACEABIO)

Please find attached newspaper copies regarding notice intimating the investors about the opening of Special Window for transfer and dematerialisation of physical shares.

Filed: 12 Aug 2026, 16:45 IST Exchange: BSE Category: Regulatory Compliance
Newspaper notice published on Aug 12, 2026, informing investors about the opening of a special window for transfer and dematerialisation of physical shares held prior to Apr 1, 2019. The window is open from Feb 5, 2026 to Feb 4, 2027, allowing shareholders to submit transfer requests including previously rejected ones. Transfers will be processed only in dematerialised form and shares will be under a one-year lock-in period post-transfer.
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 PANACEABIO — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add PANACEABIO to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Panacea Biotec Limited

Important. The summary above is generated automatically from Panacea Biotec Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.